Laparoscopic ileocecal resection is a cost-effective alternative to Remicade therapy for the treatment of ileocecal Crohn’s disease, according to results of a randomized, controlled trial.
Willem A. Bemelman, MD, PhD, of the department of surgery at Amsterdam UMC in the Netherlands, and colleagues wrote that despite recent medical advances, patients with CD still need lifelong medical therapy.
“Patients failing conventional therapy are traditionally upscaled to antitumor necrosis factor therapy, such as infliximab [Remicade, Janssen],” they wrote. “However, the LIR!C

Source link